← Open Payments lookup

RACHEL FROEHLICH: Open Payments

NPI 1538393988 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$774 in 34 payments from 18 companies in 2025. Trend: 2023 $468 · 2024 $564 · 2025 $774

Food & beverage: $774
CompanyPaymentsAmount
SANOFI-AVENTIS U.S. LLC8$224
Chiesi USA, Inc.3$68
Ascendis Pharma Endocrinology Inc3$67
PFIZER INC.3$61
Amgen Inc.2$46
Lilly USA, LLC2$40
Novo Nordisk Inc2$35
Neurocrine BioSciences, Inc.1$30
Soleno Therapeutics, Inc.1$26
Madrigal Pharmaceuticals1$25

Products named: TZIELD, MYCAPSSA, Yorvipath, SOMAVERT, MOUNJARO, Ozempic, CRENESSITY, VYKAT XR.

Industry payments across MD — which companies pay providers there.